Join Health Foundry for an exciting introductory session to productising healthtech!
Posted:
Lunch&Learn: Productising HealthTech
Mon, 19 April 2021, Online
13:30 – 14:30 CEST
Clinical need should be paramount, but without effective productisation, your solution can't be bought or used.
This session unpacks some of the key issues and decisions faced in turning HealthTech solutions into products. Productisation decisions are difficult because they force standardisation and remove customer choice. Counterintuitively, it's this reduction in choice which enables scale delivery.
Reed Jobs is keen for his $1bn venture capital fund Yosemite to make a difference.
The 34-year-old runs an oncology-focused venture capital fund that manages more than $1bn in assets, and is in the UK looking for investment opportunities.
Read…
SMA is a rare, inherited condition that causes progressive muscle weakness, affecting movement, breathing and swallowing. People living with spinal muscular atrophy (SMA) in England are set to gain routine access to two potentially life-changing treatments, following our publication of final…
Attendees
Sponsors and Exhibitors
Contact us